Library / Laws / 117th Congress / Senate Bills / S. 1425

S. 1425

To enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition, and facilitate the efficient review of petitions filed in good faith to raise legitimate public health concerns, and for other purposes.

Senate · 2 versions on the shelf